104098-48-8Cc1cnc(C2=NC(C)(C(C)C)C(=O)N2)c(C(=O)O)c1PVSGXWMWNRGTKE-UHFFFAOYSA-N5-methyl-2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid is a pyridinemonocarboxylic acid that is 5-methylpyridine-3-carboxylic acid which is substituted at position 2 by a 4,5-dihydro-imidazol-2-yl group, which in turn is substituted at positions 4, 4, and 5 by isopropyl, methyl, and oxo groups, respectively. It is an imidazolone, a member of methylpyridines, a pyridinemonocarboxylic acid and a member of imidazolines.
104098-48-8DTXSID5034270Herbicides
Active substance -> EU Pesticides database: Not approved
Pesticide (Imazapic) -> USDA PDB
log Kow = 0.393 (pH 4, 5, 6 buffer, 25 °C)
0.39
In acetone, 18.9 mg/mL at 25 °C
In water, 220 mg/L at 25 °C
In deionized water, 2150 ppm at 25 °C
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H400 (99.2%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]
P273, P391, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 133 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Tolerances are established for combined residues of the herbicide imazapic, (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-methyl-3-pyridinecarboxylic acid and its metabolite (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-hydroxymethyl-3-pyridinecarboxylic acid, both free and conjugated, in or on the following food commodities: [Table#7861]
Tolerances are also established for the combined residues of the herbicide imazapic, (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-methyl-3-pyridinecarboxylic acid and its free metabolite (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-hydroxymethyl-3-pyridinecarboxylic acid, in or on the following food commodities: [Table#7862]
New Active Ingredients ... includes chemicals not previously registered as pesticides, as well as pesticide active ingredients initially registered after November 1, 1984 and that currently have active product registrations. By law, these pesticides must meet new safety standards, such as those described in the Food Quality Protection Act of 1996 and, if new safety standards are met, will be reviewed again on a 15-year cycle. Cadre is designated by EPA as a New Pesticide Active Ingredient. Active Ingredient Number: 129041; Type of Pesticide: herbicide; Use Site: food use; Year: 1996.
Imazapyr (IMZR), Imazapic (IMZC), Imazethapyr (IMZT), Imazamox (IMZX) and Imazaquin (IMZQ) ... are classified as imidazolinone (IMI) herbicides and their mode of action is to inhibit acetohydroxyacid synthase (AHAS), an enzyme involved in the biosynthesis of the amino acids leucine, isoleucine and valine. ...
5 Crl:CD BR rats per sex per group received a single dose of (14)C- Imazapic (CL 263,222) by oral gavage or intravenous injection at 10 or 1000 mg/kg. One group received 14 consecutive non-radiolabelled daily oral doses followed by one (14)C labelled oral dose (10 mg/kg). After dosing with radiolabel, animals were housed in individual metabolism cages and sacrificed 7 days later.... Metabolites designated CL 303,459 and CL 263,284 ... and several minor radioactive components were also detected in small amounts (< 5% combined of the total radioactivity in the sample). In feces, metabolites CL 303,459 (4.29% (males) to 5.38% (females) of radioactivity in the sample), CL 263,284 (1.96% (males) and 0.85% (females)), and CL 290,610 (0.69% (males) and 0.70% (females)) were detected. The absolute amount of each of these corresponded to <0.2% of the administered dose. Several unknown metabolites accounted for less than 6% of total radioactivity in feces samples. The proposed metabolic pathway of (14)C- Imazapic ... was based on components identified in the excreta. Oxidation of the methyl group on the pyridine ring of (14)C- Imazapic produced metabolite CL 263,284. The presence of CL 303,459 suggested the initial step of ring closure, reduction to intermediate CL 280,442, followed by hydrolysis to CL 303,459 and further hydrolysis to CL 290,610.
Imazapic does not bioaccumulate in animals; if ingested, then rapidly excreted through urine and feces.
5 Crl:CD BR rats/sex/group received a single dose of (14)C- Imazapic (CL 263,222) by oral gavage or intravenous injection at 10 or 1000 mg/kg. One group received 14 consecutive non-radiolabelled daily oral doses followed by one (14)C labelled oral dose (10 mg/kg). After dosing with radiolabel, animals were housed in individual metabolism cages and sacrificed 7 days later. Feces, urine, cage wash/rinse, cage wipes (methanol extracted), blood, fat, heart, spleen, ovaries, uterus, bone (femur), brain, kidney, liver, lungs, muscle (thigh), testes, and the residual carcass were analyzed for radioactivity by liquid scintillation counting (LSC). Metabolite profiles in urine, dissolved urine precipitate, and feces extract (ethyl ether) were determined using thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC). The major elimination route for dosed radioactivity was in urine. The mean percent of total dose (including cage wash and cage wipe) ranged from 94.0% to 102% (males) and 94.5% to 102% (females). The mean percent of total dose excreted in feces ranged from 0.79% to 3.44% (males) and 0.59% to 3.50% (females). The majority of radioactivity was excreted during 6 hours post-dosing. Mean radioactivity concentrations in blood 7 days after a single dose at 10 mg/kg were not detectable. At 1000 mg/kg, concentrations were 0.127 ppm for males and <0.1 ppm for females. Mean radioactivity concentrations in tissues were generally not detectable (<0.01 ppm) at 10 and 1000 mg/kg. Residual radioactivity in the carcass ranged from <0.001 ppm to 0.043 ppm. The unchanged test article, (14)C- Imazapic, accounted for >/= 93.5% and >/= 65.9% of the total radioactivity in urine (94% to 102% of total administered dose) and feces (0.59% to 3.50% of total administered dose) respectively....
Wird geladen…
CHEMBL2251718CHEBI:147378Suitable extinguishing media: foam, dry powder, carbon dioxide, water spray. /Cadre Herbicide/
Hazards during fire-fighting: Carbon monoxide, carbon dioxide, nitrogen oxide, nitrogen dioxide, hydrocarbons. If product is heated above decomposition temperature, toxic vapors will be released. The substances/groups of substances mentioned can be released if the product is involved in a fire. /Cadre Herbicide/
Firefighters should be equipped with self-contained breathing apparatus and turn-out gear. /Cadre Herbicide/
Evacuate area of all unnecessary personnel. Contain contaminated water/firefighting water. Do not allow to enter drains or waterways. /Cadre Herbicide/
Do not contaminate water, food or feed by storage or disposal. ... Keep from freezing, do not store below 20 °F. /Cadre Herbicide/
Keep only in the original container in a cool, dry, well-ventilated place away from ignition sources, heat or flame. Protect containers from physical damage. Protect against contamination. /Cadre Herbicide/
Segregate from incompatible substances. Segregate from foods and animal feeds. Segregate from textiles and similar materials. /Cadre Herbicide/
Cleanup: Dike spillage. Pick up with suitable absorbent material. Place into suitable containers for reuse or disposal in a licensed facility. Spilled substance/product should be recovered and applied according to label rates whenever possible. If application of spilled substance/product is not possible, then spills should be contained, solidified, and placed in suitable containers for disposal. After decontamination, spill area can be washed with water. Collect wash water for approved disposal. /Cadre Herbicide/
Cleanup: Dike spillage. Pick up with suitable absorbent material. Place into suitable containers for reuse or disposal in a licensed facility. Spilled substance/product should be recovered and applied according to label rates whenever possible. If application of spilled substance/product is not possible, then spills should be contained, solidified, and placed in suitable containers for disposal. After decontamination, spill area can be washed with water. Collect wash water for approved disposal. /Cadre Herbicide/
Personal precautions: Take appropriate protective measures. Clear area. Shut off source of leak only under safe conditions. Extinguish sources of ignition nearby and downwind. Ensure adequate ventilation. Wear suitable personal protective equipment. /Cadre Herbicide/
Environmental precautions: Do not discharge into the subsoil/soil. Do not discharge into drains/surface waters/groundwater. Contain contaminated water/firefighting water. /Cadre Herbicide/
Cleanup: Dike spillage. Pick up with suitable absorbent material. Place into suitable containers for reuse or disposal in a licensed facility. Spilled substance/product should be recovered and applied according to label rates whenever possible. If application of spilled substance/product is not possible, then spills should be contained, solidified, and placed in suitable containers for disposal. After decontamination, spill area can be washed with water. Collect wash water for approved disposal. /Cadre Herbicide/
SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal and plant life; and conformance with environmental and public health regulations.
Wastes resulting from the use of this product may be disposed of on site or at an approved waste disposal facility. /Cadre Herbicide/
SRP: Wastewater from contaminant suppression, cleaning of protective clothing/equipment, or contaminated sites should be contained and evaluated for subject chemical or decomposition product concentrations. Concentrations shall be lower than applicable environmental discharge or disposal criteria. Alternatively, pretreatment and/or discharge to a permitted wastewater treatment facility is acceptable only after review by the governing authority and assurance that "pass through" violations will not occur. Due consideration shall be given to remediation worker exposure (inhalation, dermal and ingestion) as well as fate during treatment, transfer and disposal. If it is not practicable to manage the chemical in this fashion, it must be evaluated in accordance with EPA 40 CFR Part 261, specifically Subpart B, in order to determine the appropriate local, state and federal requirements for disposal.
Use this product only in accordance with its labeling and with the Worker Protection Standard, 40 CFR part 170. /Cadre Herbicide/
Do not apply this product in a way that will contact workers or other persons, either directly or through drift. Only protected handlers may be in the area during application. /Cadre Herbicide/
Do not apply directly to water, or to areas where surface water is present, or to intertidal areas blow the mean high water mark. /Cadre Herbicide/
Do not enter or allow worker entry into treated areas during the restricted entry interval (REI) of 12 hours. /Cadre Herbicide/
For more Preventive Measures (Complete) data for Imazapic (8 total), please visit the HSDB record page.
Tolerances are established for combined residues of the herbicide imazapic, (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-methyl-3-pyridinecarboxylic acid and its metabolite (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-hydroxymethyl-3-pyridinecarboxylic acid, both free and conjugated, in or on the following food commodities: [Table#7859]
Tolerances are also established for the combined residues of the herbicide imazapic, (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-methyl-3-pyridinecarboxylic acid and its free metabolite (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-hydroxymethyl-3-pyridinecarboxylic acid, in or on the following food commodities: [Table#7860]
Personal Protective Equipment (PPE). Applicators and other handlers must wear: Long-sleeved shirt and long pants; Chemical-resistant gloves made of any waterproof material; Shoes plus socks. /Cadre Herbicide/
Restricted entry interval (REI) of 12 hours. PPE required for early entry to treated areas that is permitted under the Worker Protection Standard and that involves contact with anything that has been treated, such as plants, soil, or water, is: coveralls, chemical-resistant gloves made of any waterproof material, shoes plus socks. /Cadre Herbicide/
LC50; Species: Anas platyrhynchos (Mallard Duck) diet >5000 mg/kg /Conditions of bioassay not specified in source examined/
LC50; Species: Colinus virginianus (Northern Bobwhite Quail) diet >5000 mg/kg /Conditions of bioassay not specified in source examined/
LD50; Species: Anas platyrhynchos (Mallard Duck) diet >2150 mg/kg /Conditions of bioassay not specified in source examined/
LD50; Species: Colinus virginianus (Northern Bobwhite Quail) >2150 mg/kg /Conditions of bioassay not specified in source examined/
TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 3(SRC), determined from a log Kow of 0.393(2) and a regression-derived equation(3), indicates that imazapic is expected to have very high mobility in soil(SRC). The pKa values of imazapic are 2.0, 3.6, and 11.1(2), indicating that this compound will almost entirely exist in the anion form in the environment and anions generally do not adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization from moist soil is not expected because the compound exists as an anion and anions do not volatilize. Imazapic is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 7.7X10-12 mm Hg at 25 °C(SRC), determined from a fragment constant method(5). A microbial degradation half-life range in soil of 31 to 410 days indicates biodegradation may be dependent on soil conditions(2).
AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 3(SRC), determined from a log Kow of 0.393(2) and a regression-derived equation(3), indicates that imazapic is not expected to adsorb to suspended solids and sediment(SRC). The pKa values of 2.0, 3.6, and 11.1(2) indicate imazapic will exist almost entirely in anion form at pH values of 5 to 9 and therefore volatilization from water surfaces is not expected to be an important fate process(SRC). According to a classification scheme(4), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(3), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data in water were not available(SRC, 2011).
ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), imazapic, which has an estimated vapor pressure of 7.7X10-12 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase imazapic may be removed from the air by wet or dry deposition(SRC). Imazapic absorbs light at wavelengths >290 nm(4), and therefore may be susceptible to direct photolysis by sunlight(SRC).
/AQUATIC SPECIES/ Cyprinus carpio was exposed to imazethapyr and imazapic at laboratory and at field conditions. The laboratory experiment was carried out for 7 days and at rice field for 7, 30 and 90 days. Oxidative stress parameters and antioxidant profile were studied as well as metabolic parameters. After 7 days, brain AChE activity increases in laboratory and field, but in muscle, reduction was observed only in laboratory. At the same period, brain and muscle thiobarbituric acid reactive substances (TBARS) and liver catalase cationic amino transporters (CAT) increase in the laboratory. Metabolic parameters showed changes in both conditions and exposure periods. After 30 days in rice field, brain AChE activity decreases and in muscle it was enhanced. After 90 days in field, only muscle AChE activity was reduced. The disorders in oxidative stress parameters and metabolism remained, indicating mainly a protein catabolism. This study pointed out short- and long-term effects of rice herbicides at environmentally relevant concentrations on toxicological parameters in tissues of C. carpio.
The Koc of imazapic is estimated as 3(SRC), using a log Kow of 0.393(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that imazapic is expected to have very high mobility in soil. The pKa values of imazapic are 2.0, 3.3, and 11.1(1), indicating that this compound will almost entirely exist in the anion form in the environment and anions generally do not adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4).
An estimated BCF of 3 was calculated in fish for imazapic(SRC), using a log Kow of 0.393(1) and a regression-derived equation(2). Using a modeling approach based on the quantitative structure-activity relationship (QSAR), a log BCF of -0.88215, corresponding to a BCF of >1 was calculated(3). According to a classification scheme(3), these estimated BCF values suggest the potential for bioconcentration in aquatic organisms is low(SRC).
This research was aimed at understanding the dynamics of the herbicides ... imazapic [2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methylnicotinic acid] ... in two soils of different physicochemical properties. To accomplish such intent, several greenhouse experiments were run. The bioavailability of imazapic (0; 98 and 122.5 g ha-1) was measured in samples from a sandy loam soil and a clay soil, by sowing a bioindicator (Brachiaria decumbens /signal grass/), at 0, 25, 50, 75 and 100 days after herbicides application (DAA). ... Imazapic provided a short bioavailability in relation to B. decumbens, independent of rates applied.
The pKa values of 2.0, 3.6, and 11.1(1) indicate imazapic will exist almost entirely in anion form at pH values of 5 to 9 and therefore volatilization from water and moist soil surfaces is not expected to be an important fate process. Imazapic is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 7.7X10-12 mm Hg(SRC), determined from a fragment constant method(2).
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Imazapic (AC 263,222, purity: 93.7%) was mixed with saline and the resulting slurry was applied to the clipped skin of 6 New Zealand White rabbits/sex/dose at dose levels of 0 (saline), 250, 500, or 1000 mg/kg/day for 6 hrs/day 5 days/week for 3 consecutive weeks using an occlusive dressing. No mortalities occurred. No treatment-related clinical signs were observed. No skin irritation was observed at the treatment sites. No effect on body weight was observed. Hematological and clinical chemistry investigations revealed no effects of biological significance. No effect on mean relative organ weights was observed. Macroscopic and microscopic examinations revealed no treatment-related abnormalities. ... NOEL (M/F, systemic and skin) = 1000 mg/kg/day based on no treatment-related effects at the highest dose tested.
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ 20 CD (Crl:CD (SD)) rats per sex per group received imazapic (AC 263,22, purity: 93.7%) in the diet at 0 (basal diet), 5,000, 10,000, and 20,000 ppm for 13 weeks. Average test article intake for males and females was 408, 804, and 1625 mg/kg/day at 5,000, 10,000, and 20,000 ppm respectively during the 13-week treatment period. No deaths. Food consumption was significantly increased for males at 5,000,10,000, and 20,000 ppm and for females at 10,000 ppm during the first week of the study. During the remainder of the study, food consumption for treated groups was comparable to controls. Bodyweights were slightly increased (not statistically significant) for males at 5,000 and 10,000 ppm during the 13-week study period. Bodyweights for females in all treated groups and for males at 20,000 ppm were comparable to controls over the entire study period. Bodyweight gains for treated groups (both sexes) over the 13-week period were generally comparable to controls. No treatment-related findings were noted for hematology, serum chemistry, urinalysis, necropsy, organ weights, or histopathology. ... NOEL = 20,000 ppm (1625 mg/kg/day). No adverse effects.
/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ 65 CD-1 (Crl(ICR)BR) mice/sex/group received imazapic (AC 263,222, purity: 96.9%) in the diet at 0 (basal diet); 1,750; 3,500; and 7,000 ppm for 18 months. 10 per sex/group were necropsied at 12 months. Mean daily intake of imazapic (AC 263,222) was 271 +/- 52, 551 +/- 104, and 1134 +/- 265 mg/kg/day for males and 369 +/- 87, 733 +/- 184, 1442 +/- 348 mg/kg/day for females at 1,750, 3,500, and 7,000 ppm respectively over the 18-month treatment period. Slight reductions in male bodyweight were noted through week 16, but bodyweight gain was unaffected through the 18 month study period and female bodyweight and bodyweight gain were comparable to controls. No treatment-related effects on survival, food consumption, hematology, gross pathology, organ weights, or histopathology were recorded. No evidence of oncogenicity. Chronic NOEL > or =7,000 ppm.
Imazapic is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(1). Imazapic absorbs at wavelengths >290 nm(2), and therefore it may be susceptible to direct photolysis by sunlight(SRC). When irradiated at lambda >290, imazapic (10 ppm in aqueous solution) was slowly degraded. After 2 hours, 98% of imazapic still remained; after 24 hours, imazapic decreased to 22% of original solution concentration(2).
Tolerances are established for combined residues of the herbicide imazapic, (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-methyl-3-pyridinecarboxylic acid and its metabolite (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-hydroxymethyl-3-pyridinecarboxylic acid, both free and conjugated, in or on the following food commodities: [Table#7861]
Tolerances are also established for the combined residues of the herbicide imazapic, (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-methyl-3-pyridinecarboxylic acid and its free metabolite (+/-)-2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1 H -imidazol-2-yl]-5-hydroxymethyl-3-pyridinecarboxylic acid, in or on the following food commodities: [Table#7862]
New Active Ingredients ... includes chemicals not previously registered as pesticides, as well as pesticide active ingredients initially registered after November 1, 1984 and that currently have active product registrations. By law, these pesticides must meet new safety standards, such as those described in the Food Quality Protection Act of 1996 and, if new safety standards are met, will be reviewed again on a 15-year cycle. Cadre is designated by EPA as a New Pesticide Active Ingredient. Active Ingredient Number: 129041; Type of Pesticide: herbicide; Use Site: food use; Year: 1996.
For imazapic (USEPA/OPP Pesticide Code: 129041) ACTIVE products with label matches. /SRP: Registered for use in the U.S. but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses./
For imazapic-ammonium (USEPA/OPP Pesticide Code: 128943) ACTIVE products with label matches. /SRP: Registered for use in the U.S. but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses./ /Imazapic-ammonium/
Herbicide
For post- and pre-emergence residual control of a wide range of annual and perennial weeds in pasture, rangeland and non-cropland areas.
This is a man-made compound that is used as a pesticide.
Soluble concentrate; water dispersible granule.
Premix Partners: Glyphosate; Imazapyr
Cadre Herbicide (Basf Corporation) Imazapic-ammonium 23.6%. /Imazapic-ammonium/
Plateau Herbicide (Basf Corporation) Imazapic-ammonium 23.6%. /Imazapic-ammonium/
For more Formulations/Preparations (Complete) data for Imazapic (25 total), please visit the HSDB record page.
VerwendenImazapic is registered throughout the world for use in peanuts, rangeland, sugarcane, and imidazolinoneresistant canola (12). A nonionic surfactant or oil adjuvant is required for maximum activity.
/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Six Beagle dogs /sex/group received imazapic (AC 263,222, purity: 96.9%) in the diet at 0 (basal diet), 5,000, 20,000, and 40,000 ppm for 1 year. Average compound consumption during the study was 137.4, 500.7, and 1140.8 mg/kg/day for males and 180.2, 533.8, and 1092.1 mg/kg/day for females at 5,000; 20,000; and 40,000 ppm respectively. One male died from bronchopneumonia at 40,000 ppm on day 233. An increase in salivation was noted at 20,000ppm and at 40,000 ppm. Emesis (incidence per animal) was increased for both sexes at 40,000 ppm. Food consumption was decreased at some intervals at 20,000 (females) and 40,000 ppm (both sexes). Overall bodyweight gain was decreased at 40,000 ppm in both sexes. At 5,000 ppm, clinical signs, food consumption, and bodyweight were comparable to controls. Statistically significant changes were noted for hematology. Mean hematocrit and hemoglobin were decreased in males on days 35 and 91 at 20,000 and on days 35, 42, 91, 173, and 357 at 40,000 ppm. Erythrocytes were decreased for females at 5,000 ppm (days 35, 91, and 173), 20,000 ppm (day 91), and 40,000 ppm (days 35, 42, 91, and 173), and for high dose males on days 35, 42, 91, 173, and 357. Mean corpuscular volume and mean corpuscular hemoglobin were decreased in males at 5,000 ppm (day 35), 20,000 ppm (days 91 and 173), and 40,000 ppm (days 35, 42, 91, 173, 357) and, in females, at 40,000 ppm (days 91, 173, and 357). Mean corpuscular hemoglobin concentration was decreased at 40,000 ppm for males (days 91, 173, and 357) and females (days 35, 42, 91, 173, and 357). Statistically significant treatment-related serum chemistry changes were recorded at 40,000 ppm. Increases were seen in serum potassium (days 91 and 173 in males and days 173 and 357 in females), phosphorus (days 35 and 173 in males and days 35, 42, 91, 173, and 357 in females), lactate dehydrogenase (days 35 and 91 in males and days 35, 91, and 173 in females), creatinine kinase (days 35 and 42 in both sexes, day 357 in males), aspartate aminotransferase (days 35 and 42 in both sexes), and alanine aminotransferase (days 35, 42, 91, and 173 in both sexes). Decreases in albumin (days 35 and 42 in males and days 35, 42, and 91 in females) were also noted. Urine volume and water intake were significantly decreased for males on days 176-178 and 351-353 at 20,000 and 40,000 ppm. Necropsy revealed gelatinous, red bone marrow in 3 males and all females at 40,000 ppm. Group mean absolute and relative liver weights were significantly increased for both sexes at 40,000 ppm. Microscopy indicated skeletal muscle degeneration (minimal severity) with lymphocyte and macrophage infiltration (minimal) in abdominal and vastus muscle of 3/6 males at 5,000 ppm (not in all of the same animals). 1/6 females had skeletal muscle degeneration in abdominal and vastus muscles. Skeletal myopathy of minimal severity was reported focally in only a few fibers per tissue section. Additionally, 2/6 females had minimal lymphocytic and macrophage infiltrations, one in the vastus muscle and the other in the diaphragm. At 20,000 ppm, skeletal muscle degeneration (minimal) with lymphocytic and macrophage infiltration (minimal) was present in 3/6 (vastus muscle) and 4/6 males (abdominal muscle). In females, 2/6 (vastus and abdominal muscle) had skeletal muscle degeneration (minimal) and 6/6 (vastus) and 5/6 (abdominal) had lymphocytic and macrophage infiltration (minimal). Minimal mononuclear inflammatory cell (lymphocytes and macrophages) infiltration of affected muscles was present in all animals. Two males and one female had a slight increase in bone marrow erythropoiesis. Extramedullary erythropoiesis in the spleen of one of the males was also noted. At 40,000 ppm, minimal to moderate skeletal muscle degeneration was noted in 5/6 (vastus) and 4/6 (abdominal) females and 4/5 males (vastus and abdominal). Mononuclear inflammatory cell infiltration was slight to moderate. Bone marrow erythropoiesis (slight to moderate) was increased in most animals accompanied by a slight increase in extramedullary erythropoiesis in the spleen (4/5 males, 2/6 females). Chronic NOEL < 5,000 ppm (137.4 mg/kg/day for males and 180.2 mg/kg/day for females) (skeletal muscle degeneration). ...
For more Non-Human Toxicity Excerpts (Complete) data for Imazapic (13 total), please visit the HSDB record page.